<DOC>
	<DOCNO>NCT00009893</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient unresectable metastatic biliary tract gallbladder cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Unresectable Metastatic Biliary Tract Gallbladder Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine 6-month survival overall survival patient unresectable metastatic biliary tract carcinoma gallbladder cancer treat gemcitabine , fluorouracil , leucovorin calcium . II . Determine tumor response patient treat regimen . III . Determine toxicity regimen patient . OUTLINE : Patients receive gemcitabine IV 30 minute follow leucovorin calcium IV fluorouracil IV 5-10 minute day 1 , 8 , 15 . Treatment repeat every 4 week minimum 2 course absence disease progression unacceptable toxicity . Patients follow every 3 month 1 year every 6 month 4 year .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Bile Duct Neoplasms</mesh_term>
	<mesh_term>Gallbladder Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<mesh_term>Leucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unresectable metastatic biliary tract carcinoma ( extrahepatic , intrahepatic , ampulla Vater ) gallbladder carcinoma Not amenable combine chemotherapy radiotherapy CNS metastases locally treatable ( i.e. , lesion treatable surgery radiotherapy ) allow evidence progression least 4 week completion treatment PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 3.0 time upper limit normal ( ULN ) AST great 5 time ULN Renal : Creatinine great 1.5 time ULN Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 5 year except basal cell squamous cell skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior biologic immunologic therapy No prior biologic immunologic therapy metastatic disease No concurrent immunotherapy No colony stimulate factor administer concurrently first course study therapy , within 24 hour prior subsequent course Chemotherapy : See Disease Characteristics No prior gemcitabine No prior chemotherapy metastatic disease At least 6 month since prior chemotherapy use radiosensitization either adjuvant setting locally advance disease No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy 25 % bone marrow No concurrent radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>unresectable gallbladder cancer</keyword>
	<keyword>recurrent gallbladder cancer</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
</DOC>